These results suggest that dosage effects of multiple genes induced by different mechanisms, including haploidinsufficiency of DMPK, RNA toxicity and local chromatin changes, are the major pathogenic factors in DM1 and the severity of the disease depends on the number of genes affected. This evidence concerns the gene DMPK and myotonic dystrophy type 1.